References:
*1:PoudyalH, PanchalSK, DiwanV, et al: Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action. ProgLipid Res 2011; 50: 372-387.
*2: Connor WE: Importance of n-3 fatty acids in health and disease. Am J ClinNutr2000; 71(suppl): 171S-5S.
*3: Zhang X, et al: Omega‐3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose‐Response Meta‐Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2022 Jun 7;11(11)
*4: MozurkewichEL et al. Effect of prenatal EPA and DHA on maternal and umbilical cord blood cytokines.BMC Pregnancy Childbirth. 2018; 18: 261.
*5: https://americanpregnancy.org/healthy-pregnancy/pregnancy-health-wellness/omega-3-fish-oil-and-pregnancy/
*6: KapoorK. et. al Association Between Omega-3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and AtrialFibrillation: MESA. J Am Heart Assoc. 2021 Jun;10(11)
*7: 食品藥物管理署:「食品及相關產品標示宣傳廣告涉及不實誇張易生誤解或醫療效能認定準則」
*8: GebuisE.P.A. et al. Vitamin K1 supplementation to improve the stability of anticoagulation therapy with vitamin K antagonists: a dose-finding studyHaematologica. 2011 Apr; 96(4): 583–589.
*9. Harvey W Kaufman et al. 2020. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLOS ONE 2020; 15(9):e0239252
*10. Aleksandar Radujkovic et al. 2020. Vitamin D Deficiency and Outcome of COVID-19 Patients. Nutrients 2020; 12(9):2757
*11. Xavier Nogues et al. 2021. Calcifediol treatment and COVID-19-related outcomes. J Clin Endocrinol Metab. 2021;dgab405
